Home › NDC Lookup › RxCUI directory › RxCUI 1996254

Valsartan 4 MG/ML Oral Solution — RxCUI 1996254

RxNorm drug concept · Semantic clinical drug
RxCUI 1996254 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1996254
Official nameValsartan 4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvalsartan 20 MG in 5 mL Oral Solution
FDA products mapped4
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Valsartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Valsartan is mainly used to treat high blood pressure, which helps lower your risk of stroke and heart attack. It's also used in adults with heart failure to reduce the chance of b...
  • Yes — valsartan tablets can be taken with or without food, so whatever works best for your routine is fine. If you're taking the oral solution, take it as directed by your prescrib...
  • Can I take valsartan with or without food?
  • Most people do well on valsartan. The most common issues are headache, dizziness, and fatigue. If you feel faint or lightheaded — especially when standing up — that can be a sign y...
📖 Read our full Valsartan guide →

🕸️ Concept Web — How Valsartan 4 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Valsartan 4 MG/ML Oral Solution RxCUI 1996254

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Valsartan 69749
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Valsartan Oral Solution 1996253
    • Valsartan Oral Liquid Product 1996252
    • Valsartan Oral Product 1163997
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Valsartan 4 MG/ML 1996251

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Valsartan 4 MG/ML SCDC · 1996251
  • Valsartan Oral Solution SCDF · 1996253
  • Valsartan Oral Liquid Product SCDG · 1996252
  • Valsartan Oral Product SCDG · 1163997

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 1996254 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70954-0310-10 120 mL in 1 BOTTLE, PLASTIC (70954-310-10) Valsartan ANI Pharmaceuticals, Inc. 2021-11-02
70954-0310-20 473 mL in 1 BOTTLE, PLASTIC (70954-310-20) Valsartan ANI Pharmaceuticals, Inc. 2021-11-02
72336-0910-79 120 mL in 1 BOTTLE, PLASTIC (72336-910-79) Valsartan Lifsa Drugs LLC 2022-04-04
72336-0910-89 473 mL in 1 BOTTLE, PLASTIC (72336-910-89) Valsartan Lifsa Drugs LLC 2022-04-04
72888-0184-13 473 mL in 1 BOTTLE (72888-184-13) Valsartan Advagen Pharma Ltd 2025-06-05
72888-0184-48 120 mL in 1 BOTTLE (72888-184-48) Valsartan Advagen Pharma Ltd 2025-06-05
76281-0155-56 20 mL in 1 CUP, UNIT-DOSE (76281-155-56) PREXXARTAN AptaPharma Inc. 2026-05-05
76281-0155-64 120 mL in 1 BOTTLE (76281-155-64) PREXXARTAN AptaPharma Inc. 2026-05-05
76281-0155-82 473 mL in 1 BOTTLE (76281-155-82) PREXXARTAN AptaPharma Inc. 2026-05-05
76281-0155-99 10 CUP, UNIT-DOSE in 1 TRAY (76281-155-99) / 20 mL in 1 CUP... PREXXARTAN AptaPharma Inc. 2026-05-05
Observed labelers: AptaPharma Inc. (4) · Advagen Pharma Ltd (2) · ANI Pharmaceuticals, Inc. (2) · Lifsa Drugs LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.